Peter Warthoe - Qlife Holding CoFounder Officer
| QLIFE Stock | SEK 2.18 0.14 6.86% |
Insider
Peter Warthoe is CoFounder Officer of Qlife Holding AB
| Age | 56 |
| Phone | 45 21 63 35 34 |
| Web | https://www.qlifeholding.com |
Qlife Holding Management Efficiency
The company has return on total asset (ROA) of (0.2688) % which means that it has lost $0.2688 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.6144) %, meaning that it generated substantial loss on money invested by shareholders. Qlife Holding's management efficiency ratios could be used to measure how well Qlife Holding manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Carl Fredin | Bactiguard Holding AB | 57 | |
| Fredrik Zetterberg | Episurf Medical AB | 48 | |
| Johannes Swartling | SpectraCure AB | 51 | |
| Slavoljub Grujicic | Senzime AB | 53 | |
| Stephen Caswell | Episurf Medical AB | 42 | |
| Henrik Ljung | SpectraCure AB | 65 | |
| Erica Bell | BICO Group AB | 50 | |
| Anders Goransson | Bactiguard Holding AB | 52 | |
| Jaya Tiwari | Xvivo Perfusion AB | N/A | |
| Johan Holmstrom | Xvivo Perfusion AB | 53 | |
| Mirjam Johansson | SpectraCure AB | N/A | |
| Lena BSc | Xvivo Perfusion AB | 58 | |
| Sathish Subramaniam | Bactiguard Holding AB | 44 | |
| Charlotte Walldal | Xvivo Perfusion AB | 56 | |
| Lotta Bus | BICO Group AB | 53 | |
| Anders Selin | Senzime AB | 61 | |
| Mikael Engblom | BICO Group AB | 46 | |
| Kristina Holst | SpectraCure AB | N/A | |
| Hector Martinez | BICO Group AB | 38 | |
| Itedale Redwan | BICO Group AB | N/A | |
| Carin Jakobson | Bactiguard Holding AB | 49 | |
Management Performance
| Return On Equity | -0.61 | |||
| Return On Asset | -0.27 |
Qlife Holding AB Leadership Team
Elected by the shareholders, the Qlife Holding's board of directors comprises two types of representatives: Qlife Holding inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Qlife. The board's role is to monitor Qlife Holding's management team and ensure that shareholders' interests are well served. Qlife Holding's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Qlife Holding's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jakob Lind, Global Clinical | ||
| Thomas Warthoe, CEO CoFounder | ||
| Peter Warthoe, CoFounder Officer | ||
| Kasper Rousoe, Chief Officer |
Qlife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Qlife Holding a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.61 | |||
| Return On Asset | -0.27 | |||
| Profit Margin | (1.45) % | |||
| Operating Margin | (1.58) % | |||
| Current Valuation | 55.76 M | |||
| Shares Outstanding | 23.07 M | |||
| Shares Owned By Insiders | 10.99 % | |||
| Shares Owned By Institutions | 9.73 % | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.54 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Qlife Stock Analysis
When running Qlife Holding's price analysis, check to measure Qlife Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Qlife Holding is operating at the current time. Most of Qlife Holding's value examination focuses on studying past and present price action to predict the probability of Qlife Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Qlife Holding's price. Additionally, you may evaluate how the addition of Qlife Holding to your portfolios can decrease your overall portfolio volatility.